abstract |
Compounds of the present invention are represented by the following formula (I): wherein the substituents R 1 , R 2 , R 3 , R 4 , (R 5 ) m , R 6 , A, X and Y are as defined herein. The compounds are useful in methods of treating conditions resulting from or dependent on the inhibition of GlyT-1. |